Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 06-19-2013, 08:24 AM #1
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default Safinamide Phase III Study Results Presented at 2013 MDS Meeting

Safinamide Phase III Study Results Presented at 2013 MDS Meeting

Read more here: http://www.sacbee.com/2013/06/18/550...#storylink=cpy
soccertese is offline   Reply With QuoteReply With Quote

advertisement
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In soccertese Parkinson's Disease 4 11-13-2013 10:48 AM
Dyskinesias Study Results from Phase 1/2 NP002 in the Treatment of CarolynS Parkinson's Disease Clinical Trials 1 12-03-2010 12:30 PM
Dyskinesias Study Results from Phase 1/2 NP002 CarolynS Parkinson's Disease 0 12-03-2010 11:52 AM
Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial Stitcher Parkinson's Disease Clinical Trials 0 08-29-2007 12:41 PM
Phase III Data on Safinamide ZucchiniFlower Parkinson's Disease 0 05-02-2007 06:57 PM


All times are GMT -5. The time now is 03:02 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.